NCT01134341 2019-12-18Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaAcrotech Biopharma Inc.Phase 1 Completed34 enrolled
NCT00099255 2014-12-18Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell LymphomaSeagen Inc.Phase 2 Completed40 enrolled